Among available immunotherapies, the use of ‘CAR-T’ cells is proving extremely effective against certain blood cancers, but only in half of patients. A main reason for this is the premature dysfunction of these immune cells, which have been artificially modified in vitro. A team has now discovered how to prolong the functionality of CAR-T cells. By inhibiting a very specific metabolic mechanism, the team has succeeded in creating CAR-T cells with enhanced immune memory, capable of fighting tumor cells for much longer.
Click here for original story, Strengthening artificial immune cells to fight cancer
Source: ScienceDaily